| RS41280892 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome |
| RS41281120 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS41281200 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
FANCC-related disorder, FANCC-related disorder |
| RS41281202 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group C |
| RS41281318 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS41281336 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Pituitary adenoma 5 |
| RS41281338 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 12, Usher syndrome type 1D |
| RS41281459 |
ABCG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, ABCG8-related disorder |
| RS41281487 |
ITSN2
|
Health Risk |
Conflicting classifications of pathogenicity |
ITSN2-related disorder, ITSN2-related disorder |
| RS41281550 |
KCNMA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy-paroxysmal dyskinesia syndrome, Generalized epilepsy-paroxysmal dyskinesia syndrome |
| RS41282026 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 1, Familial hyperinsulinism |
| RS41282065 |
NHERF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatemic nephrolithiasis/osteoporosis 2, Chronic kidney disease |
| RS41282224 |
MASTL
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia, MASTL-related disorder |
| RS41282930 |
KCNJ11
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal diabetes mellitus, Diabetes mellitus |
| RS41282932 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 18A, Usher syndrome type 1C |
| RS41282942 |
USH1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1C, Usher syndrome type 1C |
| RS41283530 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome, Familial cancer of breast |
| RS41283630 |
ANKS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 16, Nephronophthisis 16 |
| RS41283958 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS41284305 |
SELENON
|
Health Risk |
Conflicting classifications of pathogenicity |
Eichsfeld type congenital muscular dystrophy, SEPN1-related disorder |
| RS41284307 |
SELENON
|
Health Risk |
Conflicting classifications of pathogenicity |
SEPN1-related disorder, Eichsfeld type congenital muscular dystrophy |
| RS41284962 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 66, Retinitis pigmentosa |
| RS41285015 |
PEX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 10A (Zellweger), Peroxisome biogenesis disorder 10A (Zellweger) |
| RS41285129 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1E |
| RS41285132 |
SCN11A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial episodic pain syndrome with predominantly lower limb involvement, Hereditary sensory and autonomic neuropathy type 7 |
| RS41285286 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS41285370 |
FOXD3
|
Health Risk |
risk factor |
Autoimmune disease, susceptibility to |
| RS41285549 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS41285840 |
ATAD3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Disorder of development or morphogenesis |
| RS41286009 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS41286130 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS41286200 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 10, Dilated cardiomyopathy 1J |
| RS41286294 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS41286296 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41286298 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41286476 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS41286480 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS41286610 |
F10
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary factor X deficiency disease, Hereditary factor X deficiency disease |
| RS41286691 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Disorder of bone |
| RS41286844 |
C8B
|
Health Risk |
Pathogenic |
Type II complement component 8 deficiency, Complement component 6 deficiency |
| RS41286920 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS41287375 |
TRPM3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS41287453 |
RB1
|
Health Risk |
Pathogenic |
Retinoblastoma, Retinoblastoma |
| RS41288021 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS41288783 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS41288965 |
PEX7
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 9B, Rhizomelic chondrodysplasia punctata type 1 |
| RS41288979 |
IFNGR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 27A, Disseminated atypical mycobacterial infection |
| RS41289299 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome type 1, Imerslund-Grasbeck syndrome |
| RS41289612 |
FYCO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 18, Inborn genetic diseases |
| RS41289850 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS41289900 |
LAMA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1JJ, Cardiovascular phenotype |
| RS41290222 |
PDE6C
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia, Cone dystrophy 4 |
| RS41290587 |
SPARC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Osteogenesis imperfecta |
| RS41291047 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS41291054 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS41291058 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS41291161 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS41291450 |
PAX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal coloboma syndrome, Focal segmental glomerulosclerosis 7 |
| RS41291468 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 |
| RS41291844 |
CFAP43
|
Health Risk |
Conflicting classifications of pathogenicity |
CFAP43-related disorder, CFAP43-related disorder |
| RS41291965 |
PFKM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type VII |
| RS41292360 |
TNNC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z |
| RS41292388 |
ATP2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brody myopathy, ATP2A1-related disorder |
| RS41292592 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiomyopathy |
| RS41292780 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS41292782 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS41293104 |
MYLK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 1, Cardiomyopathy |
| RS41293445 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS41293451 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293455 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS41293457 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS41293459 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS41293461 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293463 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293465 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293475 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS41293477 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS41293479 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293481 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS41293485 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS41293487 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS41293489 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS41293493 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS41293497 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS41293499 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293501 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS41293503 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS41293505 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293507 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293509 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS41293511 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS41293513 |
BRCA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS41293517 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS41293744 |
FGFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Crouzon syndrome, Isolated Coronal Synostosis |
| RS41294982 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS41294984 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS41294986 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS41294988 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS41295061 |
IL2RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 1 diabetes mellitus 10, IL2RA-related disorder |
| RS41295182 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |